The Swiss Medical Board has ceased its activities.

The website remains available but is no longer updated after June 30, 2022.

DE | EN | FR

Completed reports

Within the framework of the Federal Health Technology Assessment (HTA) program, the benefits currently paid under the compulsory health insurance are...

Read more

Patients with moderately severe to severe Alzheimer’s disease are often prescribed a combination of cholinesterase inhibitors and mermatine. From the...

Read more

In the case of severe adiposity, surgical intervention is useful after unsuccessful conservative treatment, individual evaluation by an...

Read more

The Swiss Medical Board, in its latest report, investigated whether a herniated disc should always be operated upon. It came to the conclusion that,...

Read more

After reappraising the relevant literature, the Swiss Medical Board (SMB) came to the conclusion that, in the case of patients with severe cardiac...

Read more